Intellia Therapeutics, Inc. (NTLA)
USD 6.28
(-3.98%)
USD 6.28
(-3.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -398.79 Million USD | -38.72% |
| 2022 | 44.54 Million USD | 70.28% |
| 2021 | 26.16 Million USD | 128.31% |
| 2020 | -92.41 Million USD | -41.5% |
| 2019 | -65.31 Million USD | -11.3% |
| 2018 | -58.68 Million USD | -41.3% |
| 2017 | -41.53 Million USD | -170.36% |
| 2016 | -15.36 Million USD | -199.67% |
| 2015 | -5.12 Million USD | -209.26% |
| 2014 | -1.65 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 26.42 Million USD | 702.85% |
| 2024 Q2 | 4.35 Million USD | -83.51% |
| 2023 FY | 27.29 Million USD | -38.72% |
| 2023 Q4 | -4.38 Million USD | -145.18% |
| 2023 Q2 | 11.42 Million USD | 8.22% |
| 2023 Q1 | 10.55 Million USD | -8.54% |
| 2023 Q3 | 9.7 Million USD | -15.07% |
| 2022 Q2 | 12.19 Million USD | 28.37% |
| 2022 Q4 | 11.54 Million USD | 113.84% |
| 2022 FY | 44.54 Million USD | 70.28% |
| 2022 Q1 | 9.49 Million USD | -13.45% |
| 2022 Q3 | -83.38 Million USD | -783.88% |
| 2021 Q1 | -32.83 Million USD | -3.78% |
| 2021 FY | 26.16 Million USD | 128.31% |
| 2021 Q4 | 10.97 Million USD | 120.6% |
| 2021 Q3 | -53.28 Million USD | -1.81% |
| 2021 Q2 | -52.33 Million USD | -59.4% |
| 2020 Q3 | -17.53 Million USD | 18.47% |
| 2020 Q2 | -21.5 Million USD | 1.04% |
| 2020 Q1 | -21.73 Million USD | -4.52% |
| 2020 Q4 | -31.63 Million USD | -80.41% |
| 2020 FY | -92.41 Million USD | -41.5% |
| 2019 Q4 | -20.79 Million USD | -23.07% |
| 2019 FY | -65.31 Million USD | -11.3% |
| 2019 Q1 | -13.27 Million USD | -10.28% |
| 2019 Q2 | -14.34 Million USD | -8.03% |
| 2019 Q3 | -16.89 Million USD | -17.81% |
| 2018 Q1 | -15.02 Million USD | -3.6% |
| 2018 FY | -58.68 Million USD | -41.3% |
| 2018 Q4 | -12.03 Million USD | 23.95% |
| 2018 Q3 | -15.82 Million USD | -0.25% |
| 2018 Q2 | -15.79 Million USD | -5.1% |
| 2017 Q3 | -10.16 Million USD | -5.35% |
| 2017 FY | -41.53 Million USD | -170.36% |
| 2017 Q4 | -14.5 Million USD | -42.68% |
| 2017 Q1 | -7.21 Million USD | -26.51% |
| 2017 Q2 | -9.64 Million USD | -33.7% |
| 2016 Q1 | -3.44 Million USD | -28.56% |
| 2016 Q2 | -3.21 Million USD | 6.7% |
| 2016 FY | -15.36 Million USD | -199.67% |
| 2016 Q4 | -5.7 Million USD | -90.64% |
| 2016 Q3 | -2.99 Million USD | 6.99% |
| 2015 Q3 | -1.77 Million USD | -200.51% |
| 2015 FY | -5.12 Million USD | -209.26% |
| 2015 Q4 | -2.68 Million USD | -51.53% |
| 2015 Q1 | -85 Thousand USD | 94.24% |
| 2015 Q2 | -589 Thousand USD | -592.94% |
| 2014 Q2 | -11 Thousand USD | 0.0% |
| 2014 Q4 | -1.47 Million USD | 0.0% |
| 2014 FY | -1.65 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 431.021% |
| Jaguar Health, Inc. | 7.72 Million USD | 5263.05% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -59959.337% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -7975780.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 126.273% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 433.014% |
| ContextLogic Inc. | 59 Million USD | 775.922% |
| MiMedx Group, Inc. | 266.84 Million USD | 249.449% |
| MEI Pharma, Inc. | 49.32 Million USD | 908.47% |
| AlloVir, Inc. | -398 Thousand USD | -100099.497% |
| Novavax, Inc. | 639.93 Million USD | 162.318% |
| Aptorum Group Limited | -1.11 Million USD | -35676.289% |
| Ardelyx, Inc. | 106.66 Million USD | 473.889% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 265.657% |
| Psyence Biomedical Ltd. | -240.00 USD | -166164066.667% |
| Vaxcyte, Inc. | -75 Million USD | -431.725% |
| Precigen, Inc. | 106 Thousand USD | 376320.755% |
| Pharming Group N.V. | 220.1 Million USD | 281.184% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 77535.728% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 39623.687% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 463.293% |
| Avidity Biosciences, Inc. | -181.4 Million USD | -119.833% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -77074.086% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | -207.901% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -779.854% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -1713.772% |
| Acelyrin, Inc. | -115 Thousand USD | -346677.391% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -69741.331% |
| Senti Biosciences, Inc. | -2.68 Million USD | -14763.735% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 9944.335% |
| AbCellera Biologics Inc. | 38.02 Million USD | 1148.768% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -8211.672% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 332428.333% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 1469.062% |
| Chimerix, Inc. | 324 Thousand USD | 123184.568% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 80502.016% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -486234.146% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -1179.512% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -80955.691% |
| Elevation Oncology, Inc. | -39 Thousand USD | -1022448.718% |
| Alkermes plc | 1.37 Billion USD | 129.01% |
| Fortress Biotech, Inc. | 57.85 Million USD | 789.323% |
| Fortress Biotech, Inc. | 57.85 Million USD | 789.323% |
| Agenus Inc. | 139.61 Million USD | 385.638% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 2505.707% |
| Dyadic International, Inc. | 922.95 Thousand USD | 43308.297% |
| ImmuCell Corporation | 4.39 Million USD | 9171.161% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 1993.519% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -275.785% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -227986.912% |
| Immix Biopharma, Inc. | -5468.00 USD | -7293133.358% |
| Incyte Corporation | 3.44 Billion USD | 111.591% |
| IO Biotech, Inc. | -756 Thousand USD | -52650.529% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -751.414% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -2885.466% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -902393.89% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -306.034% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -724980.0% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 49824.938% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -75572.486% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 1457.042% |
| NextCure, Inc. | -3.68 Million USD | -10725.027% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 2194.176% |
| Onconetix, Inc. | -1.12 Million USD | -35280.268% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -1276.671% |
| Opthea Limited | 21.72 Thousand USD | 1836168.14% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -695559.91% |
| PureTech Health plc | -1.6 Million USD | -24777.979% |
| Pyxis Oncology, Inc. | -2 Million USD | -19839.7% |
| Seer, Inc. | 7.02 Million USD | 5775.167% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -3967604.706% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 5166.624% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -10016.417% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 94155.189% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 483.091% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 394.816% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -311.34% |
| ChromaDex Corporation | 50.78 Million USD | 885.337% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -171793.966% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -413.923% |
| CRISPR Therapeutics AG | 240.95 Million USD | 265.505% |
| Precision BioSciences, Inc. | 40.47 Million USD | 1085.358% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -306.257% |
| Innoviva, Inc. | 261.06 Million USD | 252.757% |
| Summit Therapeutics Inc. | -2.05 Million USD | -19353.366% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 9209.045% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 1950.982% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -336460.583% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -278191.149% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 65583.415% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 227.137% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 15593.162% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -785855.853% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -5518.4% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -83937.13% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -3834457.692% |
| Soligenix, Inc. | 97.31 Thousand USD | 409913.896% |
| Century Therapeutics, Inc. | -10.8 Million USD | -3589.462% |
| Kura Oncology, Inc. | -849 Thousand USD | -46872.203% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -494.292% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -271188.435% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 502.664% |
| Autolus Therapeutics plc | -4.86 Million USD | -8093.836% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 1063.596% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -237277.381% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 521.011% |
| GRI Bio, Inc. | 10.84 Million USD | 3778.572% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 15800.638% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -4490.699% |
| IGM Biosciences, Inc. | -211.66 Million USD | -88.413% |
| INmune Bio, Inc. | 155 Thousand USD | 257386.452% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 743.85% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -26375.23% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -61399.197% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -1362180.522% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 99302.488% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -19879.659% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -127310.224% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 522.178% |
| Verastem, Inc. | -62 Thousand USD | -643116.129% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 16477.577% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -152694.636% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 13274.562% |
| Histogen Inc. | 3.76 Million USD | 10680.897% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 69313.56% |
| Surrozen, Inc. | -27.23 Million USD | -1364.539% |
| Organovo Holdings, Inc. | -5.38 Million USD | -7300.148% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -32998.234% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -1454.934% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 2088.799% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -20141011.111% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 6673.792% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -593953.418% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 357.634% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 273621.262% |
| Apollomics, Inc. | 127 Thousand USD | 314111.024% |
| Amarin Corporation plc | 165.54 Million USD | 340.903% |
| Mesoblast Limited | -9.81 Million USD | -3963.107% |
| Turnstone Biologics Corp. | 16.5 Million USD | 2516.055% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -260.935% |
| Synaptogenix, Inc. | -6347.00 USD | -6283088.908% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -781849.02% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 347.138% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 122.689% |
| Better Therapeutics, Inc. | -2.72 Million USD | -14513.192% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -255.555% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 217.958% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -3495639.832% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -6270.511% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -35892.238% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 5549.494% |
| Insmed Incorporated | 239.63 Million USD | 266.417% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 11245.724% |
| OmniAb, Inc. | 14.66 Million USD | 2818.988% |
| Alector, Inc. | -95.05 Million USD | -319.549% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 417.458% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -817.548% |
| Zai Lab Limited | 170.9 Million USD | 333.345% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 587.065% |
| Aura Biosciences, Inc. | -1.29 Million USD | -30694.903% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 306864.615% |
| Immunic, Inc. | -111 Thousand USD | -359173.874% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 2615.416% |
| Veracyte, Inc. | 248.14 Million USD | 260.708% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 94.294% |
| FibroGen, Inc. | 128.9 Million USD | 409.373% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -70708056.028% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -3318.17% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 111.734% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 102617.738% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 212.227% |
| TG Therapeutics, Inc. | 219.1 Million USD | 282.008% |
| Galecto, Inc. | -830 Thousand USD | -47947.47% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -28693.791% |
| Fortrea Holdings Inc. | 424 Million USD | 194.055% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -362.815% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -70234.039% |
| XBiotech Inc. | -1.74 Million USD | -22766.628% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -35892.238% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -758.157% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -427.966% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 643.294% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 2473.35% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 202.507% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -703.259% |
| Vaxxinity, Inc. | -2.23 Million USD | -17751.119% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 222.048% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -3421.72% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 1730.993% |
| NexImmune, Inc. | -1.02 Million USD | -38807.795% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 7385174.074% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -5512.346% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 103.529% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -596655.802% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -11130.47% |
| Ainos, Inc. | -253.73 Thousand USD | -157070.727% |
| Pluri Inc. | 322 Thousand USD | 123949.068% |
| Prothena Corporation plc | -129.2 Million USD | -208.662% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 890.882% |
| Celularity Inc. | 6.75 Million USD | 6003.686% |
| Rallybio Corporation | -150 Thousand USD | -265762.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -1123.032% |
| MeiraGTx Holdings plc | 287 Thousand USD | 139052.613% |
| Omeros Corporation | -69.77 Million USD | -471.51% |
| Humacyte, Inc. | -76.55 Million USD | -420.959% |
| Immunocore Holdings plc | 248.39 Million USD | 260.551% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -2529.007% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 739.277% |
| Blueprint Medicines Corporation | 236.58 Million USD | 268.563% |
| CalciMedica, Inc. | -58 Thousand USD | -687475.862% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -27865.919% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 1472.549% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -13922.293% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -1192.059% |
| Pulmatrix, Inc. | -8.22 Million USD | -4751.509% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -33984.957% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -99848.371% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 14467.926% |
| Cytokinetics, Incorporated | -322.59 Million USD | -23.621% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 46358.17% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -116848.387% |
| Vor Biopharma Inc. | -3.49 Million USD | -11320.218% |
| Roivant Sciences Ltd. | 109.23 Million USD | 465.079% |
| Evogene Ltd. | 1.39 Million USD | 28605.647% |
| ProKidney Corp. | -3.16 Million USD | -12484.222% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -808.166% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 5915.867% |
| CorMedix Inc. | -205.56 Thousand USD | -193901.81% |
| BioLineRx Ltd. | 1.1 Million USD | 36092.238% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -406.914% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -1208366.667% |
| Atai Life Sciences N.V. | -5000.00 USD | -7975780.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -327158.553% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -415310.417% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -28610.871% |
| Sagimet Biosciences Inc. | 2 Million USD | 20039.7% |
| MediciNova, Inc. | 979.7 Thousand USD | 40805.518% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -372.959% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -421658.765% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1824.61% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 263.083% |
| Biomea Fusion, Inc. | -4.2 Million USD | -9392.835% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 145.716% |
| Mereo BioPharma Group plc | 7.42 Million USD | 5470.24% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -128543.226% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -3323183.333% |
| Absci Corporation | -41.84 Million USD | -852.936% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -7975780.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -422.166% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -16104.551% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 286.583% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -42279.809% |
| Allakos Inc. | -6.14 Million USD | -6393.959% |
| Imunon, Inc. | -720 Thousand USD | -55287.671% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -477.996% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 183.799% |
| BioAtla, Inc. | -103.73 Million USD | -284.45% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -3495639.832% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -223941.573% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | -64.235% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -128129.582% |
| XOMA Corporation | 3.86 Million USD | 10428.775% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -469.015% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 2795.647% |
| aTyr Pharma, Inc. | -2.38 Million USD | -16599.916% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 3300.594% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -1375051.724% |
| Viridian Therapeutics, Inc. | -1 Million USD | -39462.897% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 3067646253.846% |
| Akari Therapeutics, Plc | -4000.00 USD | -9969750.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 162.616% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 204916.443% |
| UroGen Pharma Ltd. | 73.35 Million USD | 643.672% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -1393.946% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 3435018.174% |
| Orgenesis Inc. | -5.72 Million USD | -6865.834% |
| Entera Bio Ltd. | -56 Thousand USD | -712032.143% |
| GH Research PLC | -315 Thousand USD | -126501.27% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -210902.116% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -75860.762% |
| Xencor, Inc. | -85.26 Million USD | -367.739% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -180368.556% |
| Replimune Group, Inc. | -2.65 Million USD | -14920.49% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -39730.17% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 324.238% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 204916.443% |
| Portage Biotech Inc. | -54 Thousand USD | -738407.407% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -421658.765% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -105680.902% |
| OncoCyte Corporation | 413 Thousand USD | 96660.291% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -8871846.607% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -179636836.937% |
| Purple Biotech Ltd. | -196 Thousand USD | -203366.327% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 4546.855% |
| scPharmaceuticals Inc. | 9.78 Million USD | 4176.815% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -3718.053% |
| HilleVax, Inc. | -2.15 Million USD | -18396.939% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -411027.835% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -2657817.889% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -59599.701% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -1733786.957% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -5312789.68% |
| Savara Inc. | -44.26 Million USD | -800.985% |
| Curis, Inc. | 9.81 Million USD | 4164.764% |
| Daré Bioscience, Inc. | 2.76 Million USD | 14499.38% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -319477.203% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -22965.009% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -174809.649% |
| BeiGene, Ltd. | 2.07 Billion USD | 119.183% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -14163.529% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 0.218% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 803.489% |
| Erasca, Inc. | -3.73 Million USD | -10585.798% |
| bluebird bio, Inc. | -4.03 Million USD | -9795.633% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1413161.039% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 120.941% |
| DBV Technologies S.A. | 15.72 Million USD | 2635.567% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1413161.039% |
| Moderna, Inc. | 2.15 Billion USD | 118.506% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -43484.044% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 5081.189% |
| Molecular Templates, Inc. | 50.39 Million USD | 891.336% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -74301.866% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 398.079% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -6309.418% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -913.634% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -258.86% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -11014.66% |
| MacroGenics, Inc. | 50.52 Million USD | 889.269% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -6439.751% |
| Prime Medicine, Inc. | -147.9 Million USD | -169.628% |
| Aditxt, Inc. | -111.66 Thousand USD | -357050.278% |
| Adagene Inc. | 18.11 Million USD | 2301.884% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 81820.082% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 384.442% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 352.664% |
| SciSparc Ltd. | 2.19 Million USD | 18260.018% |
| Vericel Corporation | 135.57 Million USD | 394.148% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1591955.571% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -1287079.653% |
| Generation Bio Co. | -73.91 Million USD | -439.56% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -91157.208% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 830.138% |
| Invivyd, Inc. | -2.02 Million USD | -19564.398% |
| Relay Therapeutics, Inc. | -300.84 Million USD | -32.56% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -385439.164% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 513.824% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 505.74% |
| ADMA Biologics, Inc. | 88.21 Million USD | 552.055% |
| Clene Inc. | 533 Thousand USD | 74920.638% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 1754.117% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -41571.264% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1824.61% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 20160.06% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -205129.626% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 900.711% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -5523.153% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -47602.632% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 578.084% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 545556.286% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 850.149% |
| Verve Therapeutics, Inc. | -173.18 Million USD | -130.267% |
| Trevena, Inc. | 1.45 Million USD | 27508.522% |
| Surrozen, Inc. | -27.23 Million USD | -1364.539% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -112872.805% |
| Cingulate Inc. | -582.91 Thousand USD | -68313.396% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -1286332.258% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -1924.438% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -5267984.544% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -45166.061% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 158.585% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -40263.765% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -707709.449% |
| Kronos Bio, Inc. | 1.37 Million USD | 29166.618% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -643.104% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -136473.288% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -81567.534% |
| ImmunityBio, Inc. | -17.89 Million USD | -2129.145% |
| Korro Bio, Inc. | -3.63 Million USD | -10886.061% |
| Kineta, Inc. | 5.43 Million USD | 7440.217% |
| BioVie Inc. | -229.37 Thousand USD | -173759.628% |
| Codexis, Inc. | 57.33 Million USD | 795.563% |
| Celularity Inc. | 6.75 Million USD | 6003.686% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 10037.553% |
| Celcuity Inc. | -142.77 Thousand USD | -279222.276% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 788386.223% |
| Cibus, Inc. | 1.42 Million USD | 28144.585% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -106529.412% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -1640.015% |
| IN8bio, Inc. | -2.5 Million USD | -15845.382% |
| Kodiak Sciences Inc. | -25.94 Million USD | -1436.956% |
| Annexon, Inc. | -3.26 Million USD | -12106.734% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -19410.47% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -855.493% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 62411.563% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 151.225% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 330.577% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -20889.158% |
| Arcellx, Inc. | 108.27 Million USD | 468.302% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -1132.024% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 603.502% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -1785.373% |
| Moolec Science SA | -143.3 Thousand USD | -278183.382% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -842.374% |
| Geron Corporation | -123.5 Million USD | -222.902% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 12232.461% |
| Royalty Pharma plc | 1.79 Billion USD | 122.231% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -468.974% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -11040708.416% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 172446.375% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -257.939% |
| Humacyte, Inc. | -76.55 Million USD | -420.959% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -41914.847% |
| 89bio, Inc. | -273 Thousand USD | -145978.388% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -31625.855% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -46927.594% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -324122.764% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 35738.427% |
| Notable Labs, Ltd. | 113 Thousand USD | 353015.044% |
| Liquidia Corporation | 14.6 Million USD | 2831.466% |
| Mustang Bio, Inc. | -2.22 Million USD | -17823.326% |
| Immunovant, Inc. | -231 Thousand USD | -172538.095% |
| Quantum-Si incorporated | 488 Thousand USD | 81820.082% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -617.785% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -1329213.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 21517.508% |
| Acasti Pharma Inc. | -11 Thousand USD | -3625300.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -194797.785% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -61399.197% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | -138.069% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 35249.042% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -104570.341% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -20267.416% |
| PepGen Inc. | -1.18 Million USD | -33581.926% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -313911.024% |
| United Therapeutics Corporation | 2.07 Billion USD | 119.265% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1641.687% |
| Solid Biosciences Inc. | -76.56 Million USD | -420.87% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -482800.839% |
| Immuneering Corporation | -764.13 Thousand USD | -52088.741% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 601926.029% |
| Belite Bio, Inc | -399 Thousand USD | -99848.371% |
| XOMA Corporation | 3.86 Million USD | 10428.775% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -1890.387% |
| Bionomics Limited | -434.44 Thousand USD | -91693.053% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -37031.657% |
| uniQure N.V. | 2.21 Million USD | 18104.244% |
| Cassava Sciences, Inc. | -89.42 Million USD | -345.964% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -333.147% |
| Forte Biosciences, Inc. | -9000.00 USD | -4430944.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -47659.76% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -91157.208% |
| Altimmune, Inc. | -65.37 Million USD | -510.029% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 210.155% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -37031.657% |
| Compugen Ltd. | 31.45 Million USD | 1367.824% |
| Peak Bio, Inc. | 367.76 Thousand USD | 108536.002% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 1726.668% |
| Benitec Biopharma Inc. | 108 Thousand USD | 369353.704% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -511174.359% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -33049.958% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -21787.706% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -335021.008% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -33049.958% |
| Instil Bio, Inc. | -4.75 Million USD | -8285.071% |
| argenx SE | 1.1 Billion USD | 135.977% |
| Immunome, Inc. | -8.9 Million USD | -4377.31% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -21000.212% |
| Verona Pharma plc | -679.62 Thousand USD | -58578.622% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -227782.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | -16620.922% |
| CervoMed Inc. | -1.29 Million USD | -30727.588% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -16468.093% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -8248.21% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 16238.972% |
| Moolec Science SA | -143.3 Thousand USD | -278183.382% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -97636.441% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -14827.562% |
| AnaptysBio, Inc. | 14.78 Million USD | 2798.018% |
| Design Therapeutics, Inc. | -537 Thousand USD | -74163.315% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -93294.379% |
| NeurAxis, Inc. | 2.15 Million USD | 18590.901% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 18683.131% |
| Lumos Pharma, Inc. | 2 Million USD | 19970.154% |
| Achilles Therapeutics plc | -4.73 Million USD | -8328.905% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -227782.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -377277.809% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 1359.664% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 46358.17% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -38542.829% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -775.547% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 927527.907% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -48415.085% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -3030710.154% |
| Palisade Bio, Inc. | 246 Thousand USD | 162211.382% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -1208366.667% |
| Beam Therapeutics Inc. | -59.67 Million USD | -568.31% |
| Neurogene Inc. | -3.26 Million USD | -12125.445% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 386.212% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -10701.571% |
| Sesen Bio, Inc. | 40 Million USD | 1096.985% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -134174.074% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -9802.914% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -4068.869% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 2932.344% |
| Athira Pharma, Inc. | -969 Thousand USD | -41055.212% |
| Vaccinex, Inc. | -16 Million USD | -2391.84% |
| HCW Biologics Inc. | -574.82 Thousand USD | -69276.714% |
| XOMA Corporation | 3.86 Million USD | 10428.775% |
| Nektar Therapeutics | 53.47 Million USD | 845.716% |
| Arvinas, Inc. | 71.8 Million USD | 655.423% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -377.821% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -535.275% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -123749.068% |
| Rezolute, Inc. | -36 Thousand USD | -1107661.111% |
| Clene Inc. | 533 Thousand USD | 74920.638% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -31058622.741% |
| BeyondSpring Inc. | 1.75 Million USD | 22875.214% |
| Synlogic, Inc. | -1.92 Million USD | -20627.339% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -1077721.622% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -6198.073% |
| Peak Bio, Inc. | 367.76 Thousand USD | 108536.002% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -2003.011% |
| Krystal Biotech, Inc. | 47.6 Million USD | 937.715% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 382.65% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 8036.199% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -15302.096% |
| MannKind Corporation | 136.19 Million USD | 392.82% |
| Ikena Oncology, Inc. | -50.49 Million USD | -689.816% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 466.491% |
| Gossamer Bio, Inc. | -4.38 Million USD | -8994.504% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -158151.587% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -7975780.0% |
| Legend Biotech Corporation | 140.92 Million USD | 382.975% |
| Mural Oncology plc | -2.56 Million USD | -15435.411% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -72276.407% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -398694.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 2021.528% |
| REGENXBIO Inc. | 53.02 Million USD | 852.03% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -7344.418% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -207200.325% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -22925.058% |
| Vaxart, Inc. | -60.76 Million USD | -556.311% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -151659.647% |
| Cellectis S.A. | 18 Thousand USD | 2215622.222% |
| Longeveron Inc. | 221 Thousand USD | 180549.774% |
| Repare Therapeutics Inc. | -80.07 Million USD | -398.057% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 136.486% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -30718.702% |
| Revolution Medicines, Inc. | -399.66 Million USD | 0.218% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -1139311.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 813965.306% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 104.633% |
| Denali Therapeutics Inc. | -93.34 Million USD | -327.226% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1591955.571% |
| Veru Inc. | 7.56 Million USD | 5370.92% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -264001.987% |
| Cingulate Inc. | -582.91 Thousand USD | -68313.396% |
| Passage Bio, Inc. | -3.72 Million USD | -10617.388% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -3311042.478% |
| Exicure, Inc. | -1.42 Million USD | -27924.877% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -104023.76% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 14853.755% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -77686.902% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 685.377% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -266461.057% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -573.57% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 102093.35% |
| OmniAb, Inc. | 14.66 Million USD | 2818.988% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 2094.668% |
| Lipocine Inc. | -2.85 Million USD | -13888.757% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -21538.307% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -6890.254% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -26375.23% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 629.494% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -613429.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 573.088% |
| Ocugen, Inc. | -33.53 Million USD | -1089.116% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -12512.081% |
| Q32 Bio Inc. | 578 Thousand USD | 69095.502% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -150388.302% |
| Alumis Inc. Common Stock | -1.28 Million USD | -30958.723% |
| Equillium, Inc. | 35.95 Million USD | 1209.055% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -23262.273% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 79750.634% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -9646586.018% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -153874.517% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 94441.774% |
| Dominari Holdings Inc. | 2.03 Million USD | 19658.313% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -217260.782% |
| vTv Therapeutics Inc. | -13.59 Million USD | -2833.387% |
| Bio-Techne Corporation | 773.07 Million USD | 151.585% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 2402.639% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 186.546% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -34014.115% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -1563.028% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 3509.37% |
| Nkarta, Inc. | -5.86 Million USD | -6694.922% |
| BioCardia, Inc. | -7.24 Million USD | -5401.366% |
| Iterum Therapeutics plc | -1.75 Million USD | -22688.229% |